Ophthalmology laser maker Iridex secures large tender from Government of Zambia

Iridex (NASDAQ: IRIX; Mountain View, CA) has been awarded a competitive tender for more than $350,000 in ophthalmology laser equipment by the government of Zambia.

Related: Iridex to fill large orders from developing countries for ophthalmic laser systems

Diabetes continues to grow rapidly in many developing parts of the world, and with that comes the spread of related eye diseases such as diabetic macular edema (DME), explains Will Moore, the company's president and CEO. Recognizing that health systems in many countries cannot support the use of injectable drugs for these diseases due to logistics and cost, the company's laser-based treatments are as effective as drugs in terms of long-term outcomes, are much less costly to a healthcare system, and are much easier to administer from a logistics standpoint because they provide durable results, he adds.

Moore adds that the advances in laser therapies are also ushering in a paradigm shift in the U.S. and European ophthalmology markets, including DME and glaucoma treatments, as they achieve durable results against their progression without harming healthy tissue.

-----

Follow us on Twitter, 'like' us on Facebook, connect with us on Google+, and join our group on LinkedIn

Subscribe now to BioOptics World magazine; it's free!

Get All the BioOptics World News Delivered to Your Inbox

Subscribe to BioOptics World Magazine or email newsletter today at no cost and receive the latest news and information.

 Subscribe Now
Related Articles

Eye test that pairs two in vivo imaging methods may detect Parkinson's earlier

A low-cost, noninvasive eye test pairs two in vivo imaging methods to help detect Parkinson's before clinical symptoms appear.

Lightweight handheld probe for OCT provides insight into children's retinas

A handheld device is capable of capturing OCT images of a retina with cellular resolution in infants and toddlers.

NeuroVision receives $10M in financing for optical imaging device to detect Alzheimer's

NeuroVision Imaging has raised Series B financing for its optical imaging device to detect and monitor Alzheimer's disease early.  

Optical elastography method targets corneal disease, with implications for other eye diseases

Optical elastography could lead to more effective therapies for degenerative corneal disease and other eye diseases.

BLOGS

Neuro15 exhibitors meet exacting demands: Part 2

Increasingly, neuroscientists are working with researchers in disciplines such as chemistry and p...

Why be free?

A successful career contributed to keeping OpticalRayTracer—an optical design software program—fr...

LASER Munich 2015 is bio-bent

LASER World of Photonics 2015 included the European Conferences on Biomedical Optics among its si...

White Papers

Understanding Optical Filters

Optical filters can be used to attenuate or enhance an image, transmit or reflect specific wavele...

How can I find the right digital camera for my microscopy application?

Nowadays, image processing is found in a wide range of optical microscopy applications. Examples ...

CONNECT WITH US

            

Twitter- BioOptics World

Copyright © 2007-2016. PennWell Corporation, Tulsa, OK. All Rights Reserved.PRIVACY POLICY | TERMS AND CONDITIONS